Marketing of Clozaril

Marketing of Clozaril
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights
Publisher:
Total Pages: 144
Release: 1991
Genre: Antipsychotic drugs
ISBN:

The Clozapine Handbook

The Clozapine Handbook
Author: Jonathan M. Meyer
Publisher: Cambridge University Press
Total Pages: 331
Release: 2019-05-16
Genre: Medical
ISBN: 1108668429

Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management, as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals.

Treatment–Refractory Schizophrenia

Treatment–Refractory Schizophrenia
Author: Peter F. Buckley
Publisher: Springer Science & Business Media
Total Pages: 231
Release: 2014-03-18
Genre: Medical
ISBN: 3642452574

Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.

Psychosis and Schizophrenia in Children and Young People

Psychosis and Schizophrenia in Children and Young People
Author: National Collaborating Centre for Mental Health (Great Britain)
Publisher: RCPsych Publications
Total Pages: 512
Release: 2013
Genre: Medical
ISBN: 9781908020604

These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment.

Management of Chronic Schizophrenia

Management of Chronic Schizophrenia
Author: Carol L. M. Caton
Publisher: Oxford University Press, USA
Total Pages: 232
Release: 1984
Genre: Psychology
ISBN:

This first full account of the problems posed by deinstitutionalization of chronic schizophrenic patients reports on innovations in hospital treatment and community-based aftercare, housing and community residence programs, counseling for families of schizophrenic patients, and the available methods of psychiatric, psychosocial, and parmacologic therapy, including psychiatric outpatient services.

A Concise Guide to Understanding Suicide

A Concise Guide to Understanding Suicide
Author: Stephen H. Koslow
Publisher: Cambridge University Press
Total Pages: 409
Release: 2014-09-18
Genre: Medical
ISBN: 1107033233

A concise review of current research into suicide providing a guide to understanding this disease and its increasing incidence globally.

Clinical Psychopharmacology

Clinical Psychopharmacology
Author: S. Nassir Ghaemi
Publisher: Oxford University Press
Total Pages: 601
Release: 2018-12-05
Genre: Medical
ISBN: 0199995508

Clinical Psychopharmacology offers a comprehensive guide to clinical practice that explores two major aspects of the field: the clinical research that exists to guide clinical practice of psychopharmacology, and the application of that knowledge with attention to the individualized aspects of clinical practice. The text consists of 50 chapters, organized into 6 sections, focusing on disease-modifying effects, non-DSM diagnostic concepts, and essential facts about the most common drugs. This innovative book advocates a scientific and humanistic approach to practice and examines not only the benefits, but also the harms of drugs. Providing a solid foundation of knowledge and a great deal of practical information, this book is a valuable resource for practicing psychiatrists, psychiatric nurse practitioners, medical students and trainees in psychiatry, as well as pharmacists.

Registries for Evaluating Patient Outcomes

Registries for Evaluating Patient Outcomes
Author: Agency for Healthcare Research and Quality/AHRQ
Publisher: Government Printing Office
Total Pages: 385
Release: 2014-04-01
Genre: Medical
ISBN: 1587634333

This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.

The Development of American Pharmacology

The Development of American Pharmacology
Author: John Parascandola
Publisher:
Total Pages: 240
Release: 1992
Genre: Medical
ISBN:

"The word pharmacology has been used since the seventeenth century to refer - like the ancient term materia medica - to the general study of drugs, including their origin, composition, physiological effects, therapeutic uses, preparation, and administration. But the modern science of pharmacology did not emerge as a distinct discipline until the nineteenth century, when scientists primarily concerned with investigating the physiological effects of drugs began calling themselves "pharmacologists."" "The Development of American Pharmacology is the first comprehensive history of the emergence of the science of pharmacology as an independent discipline in the United States. Central to the story is John J. Abel (1857-1938), widely regarded as the "father of American pharmacology." A student of the University of Michigan and Johns Hopkins, Abel received his M.D. degree at the University of Strassburg and helped introduce German knowledge of pharmacology to his American colleagues. At the University of Michigan, he was appointed to the first chair of pharmacology in the United States, and as professor of pharmacology at Johns Hopkins for thirty-nine years, he trained many of the leading figures in the discipline." "In addition to offering the first detailed portrait of Abel's education and career, Parascandola treats topics such as the beginnings of experimental pharmacology in the nineteenth century; the spread of American pharmacology from Michigan and Johns Hopkins to other universities; the growth of pharmacology outside the academic setting; and the establishment of a national society of pharmacologists and a specialized journal, the Journal of Pharmacology and Experimental Therapeutics."--BOOK JACKET.Title Summary field provided by Blackwell North America, Inc. All Rights Reserved